Gisbert J P, Blanco M, Pajares J M
Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid.
Rev Clin Esp. 2000 Sep;200(9):480-4. doi: 10.1016/s0014-2565(00)70700-4.
To evaluate the effect of Helicobacter pylori eradication on pathologic lesions over the gastric mucosa during an 18-month follow-up period.
A total of 122 duodenal ulcer patients infected with H. pylori were prospectively studied. Patients were randomized to receive: ranitidine alone, ranitidine plus antibiotics, or bismuth plus antibiotics. An endoscopy was performed at 3, 6, 12 and 18 months. Haematoxylin-eosin, Giemsa, and Warthin-Starry staining methods were used. Histologic lesions were classified according to the following score: normal (0); superficial chronic gastritis (CG): mild (0.5), moderate (1) and severe (1.5); atrophic CG: mild (2), moderate (3) and severe (4); intestinal metaplasia: absence (0), mild (1), moderate (2) and severe (3). The acute inflammatory activity (active CG) was scored from 0 to 3 (absence, mild, moderate, severe) regarding: inflammatory density in the lamina propria, density of plymorphonuclear leukocytes in the lamina propria, density of intra-epithelial polymorphonuclear leukocytes and superficial erosions.
H. pylori eradication was achieved in 31% of patients (0% in the group of ranitidine alone and 48% in patients who received antibiotics). The score corresponding to CG declined progressively after H. pylori eradication, with average values of 2.1 +/- 1.3, 1.98 +/- 1.4, 1.73 +/- 1.6, 1.43 +/- 1.9 and 1.38 +/- 1.9 (p < 0.0001) at 0, 3, 6, 12 and 18 months, respectively. The corresponding score for active CG also improved progressively after eradication: 7.82 +/- 1, 2.51 +/- 0.7, 1.24 +/- 0.6, 0.45 +/- 1.6 and 0.12 +/- 0.5 (p < 0.0001). Nevertheless, no changes were observed regarding atrophia or intestinal metaplasia conditions.
H. pylori eradication is associated with a histologic improvement of gastric mucosa. It begins early and continues for the 18 months after therapy. The improvement in the overall inflammatory component is slow and progressive. In contrast, improvement of the acute component in gastritis is more marked early, and is observed immediately after eradication. Nevertheless, H. pylori eradication is not followed by an improvement in atrophy or intestinal metaplasia.
评估在18个月的随访期内,根除幽门螺杆菌对胃黏膜病理病变的影响。
前瞻性研究了122例感染幽门螺杆菌的十二指肠溃疡患者。患者被随机分为:单独使用雷尼替丁、雷尼替丁加抗生素、铋剂加抗生素。在3、6、12和18个月时进行内镜检查。使用苏木精-伊红、吉姆萨和沃辛-斯塔里染色方法。组织学病变根据以下评分分类:正常(0);浅表性慢性胃炎(CG):轻度(0.5)、中度(1)和重度(1.5);萎缩性CG:轻度(2)、中度(3)和重度(4);肠化生:无(0)、轻度(1)、中度(2)和重度(3)。急性炎症活动度(活动性CG)根据以下方面评分为0至3分(无、轻度、中度、重度):固有层炎症密度、固有层多形核白细胞密度、上皮内多形核白细胞密度和浅表糜烂。
31%的患者实现了幽门螺杆菌根除(单独使用雷尼替丁组为0%,接受抗生素治疗的患者为48%)。根除幽门螺杆菌后,CG对应的评分逐渐下降,在0、3、6、12和18个月时的平均值分别为2.1±1.3、1.98±1.4、1.73±1.6、1.43±1.9和1.38±1.9(p<0.0001)。根除后,活动性CG的相应评分也逐渐改善:7.82±1、2.51±0.7、1.24±0.6、0.45±1.6和0.12±0.5(p<0.0001)。然而,在萎缩或肠化生情况方面未观察到变化。
根除幽门螺杆菌与胃黏膜组织学改善相关。这种改善在治疗后早期开始,并持续18个月。整体炎症成分的改善缓慢且渐进。相比之下,胃炎急性成分的改善在早期更明显,且在根除后立即观察到。然而,根除幽门螺杆菌后萎缩或肠化生并未改善。